or
forgot password

    • cancer clinical trials in buffalo, NY

    • Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Chronic Lymphocytic Leukemia
    Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Acute Myeloid Leukemia
    Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Anaplastic Large-Cell Lymphoma
    Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Breast Cancer
    Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Glioblastoma Multiforme
    Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Colorectal Cancer, Diarrhea
    Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Unspecified Adult Solid Tumor, Protocol Specific
    Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Brain Tumor, Central Nervous System Tumor
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Endometrial Cancer
    Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Colorectal Cancer
    A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy
    VAWNY, Buffalo
    Buffalo, New York 14215
    Prostate Cancer
    RNA-Loaded Dendritic Cell Cancer Vaccine
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Renal Cell Carcinoma
    Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Non-Hodgkin Lymphoma, Chronic Myelogenous Leukemia
    Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Leukemia
    Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Lymphoma, Non-Hodgkin
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Brain and Central Nervous System Tumors
    Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Lymphoma, Non-Hodgkin
    Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Multiple Myeloma
    Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Breast Neoplasm
    Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
    Roswell Park Cancer Center
    Buffalo, New York 14263
    Myelodysplastic Syndrome, Iron Overload
    Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Leukemia
    Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Unspecified Adult Solid Tumor, Protocol Specific
    Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Hemoglobinuria, Paroxysmal
    Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Leukemia, Myeloid, Acute
    Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Graft vs Host Disease
    Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage III Colon Cancer, Stage III Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Multiple Myeloma
    Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)
    Roswell Park Cancer Center
    Buffalo, New York 14263
    Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma
    Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
    Jacobs Neurological Institute
    Buffalo, New York 14203
    Multiple Sclerosis, Optic Neuritis, Transverse Myelitis, Acute Brainstem/Cerebellar Syndrome
    A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Lymphoma, B-Cell
    Fulvestrant in Treating Patients With Recurrent Prostate Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Prostate Cancer
    Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Prostate Cancer
    Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Brain Metastasis, Non-small Cell Lung Cancer
    Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Tumor Lysis Syndrome, Cancer, Hyperuricemia
    Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Unspecified Adult Solid Tumor, Protocol Specific
    Fulvestrant in Treating Patients With Advanced Prostate Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Prostate Cancer
    Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Multiple Myeloma and Plasma Cell Neoplasm
    Amonafide in Combination With Cytarabine in Secondary AML
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Acute Myeloid Leukemia
    Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer
    Rosewell Park Cancer Institute Elm & Carlton Carlton Building
    Buffalo, New York
    Breast Neoplasms, Neoplasm Metastasis
    A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
    Roswell Park Cancer Center
    Buffalo, New York 14263
    Hodgkin's Disease
    Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
    Roswell Park Cancer Institute Corporation
    Buffalo, New York 14263
    Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myelodysplastic Syndrome
    Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Multiple Myeloma
    Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Chronic Myeloid Leukemia
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Roswell Park Cancer Institute

    Trial Locations
    Roswell Park Cancer Institute
    Veterans Affairs Western New York Health Care System-Buffalo
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer